Edition:
United Kingdom

DelMar Pharmaceuticals Inc (DMPI.OQ)

DMPI.OQ on NASDAQ Stock Exchange Capital Market

0.45USD
7:03pm GMT
Change (% chg)

$0.04 (+8.70%)
Prev Close
$0.41
Open
$0.44
Day's High
$0.45
Day's Low
$0.41
Volume
30,644
Avg. Vol
17,939
52-wk High
$1.59
52-wk Low
$0.31

Chart for

About

DelMar Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company focuses on the treatment of cancer. The Company is engaged in conducting clinical trials in the United States with its product candidate, VAL-083, as a treatment for glioblastoma multiforme (GBM), a form of brain cancer. VAL-083 is being... (more)
No analyst recommendations are available for .

Overall

Beta: 0.80
Market Cap(Mil.): $19.05
Shares Outstanding(Mil.): 21.55
Dividend: --
Yield (%): --

Financials

  DMPI.OQ Industry Sector
P/E (TTM): -- 8.16 19.22
EPS (TTM): -0.85 -- --
ROI: -992.44 14.04 0.45
ROE: -- 17.15 15.43

Earnings vs. Estimates